Unknown PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT04621799

Fibrin for Chronic Multi-level Discogenic Low Back Pain

A Prospective Registry Study Evaluating the Safety and Efficacy of Fibrin for Chronic Multi-level Discogenic Low Back Pain

Sponsor: Pauza, Kevin, MD

Conditions Annular Disc Tear Disc Degeneration Disc Disease Low Back Pain Radiculopathy

Interventions Fibrin sealant

Updated 5 times since 2020 Last updated: Nov 5, 2020 Started: Jun 11, 2018 Primary completion: Dec 31, 2020 Completion: Jun 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04621799, this PHASE2/PHASE3 trial focuses on Annular Disc Tear and Disc Degeneration and remains ongoing. Sponsored by Pauza, Kevin, MD, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Dec 2022 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3

Status: Recruiting → Unknown Status
Jan 2021 — Dec 2022 [monthly]

Recruiting PHASE2_PHASE3
Dec 2020 — Jan 2021 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Jun 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pauza, Kevin, MD

Data source: Pauza, Kevin, MD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tyler, United States